Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Organic Solvents Workup

  • Author: Jonathan S Rutchik, MD, MPH; Chief Editor: Tarakad S Ramachandran, MBBS, MBA, MPH, FAAN, FACP, FAHA, FRCP, FRCPC, FRS, LRCP, MRCP, MRCS  more...
 
Updated: May 02, 2014
 

Laboratory Studies

See the list below:

  • Laboratory tests: Many laboratory tests should be routinely performed to rule out common diagnoses in the differential. Detailed discussions of these may be found in other articles in the Medscape Reference journal. To confirm exposure to an organic solvent, monitoring of the biologic exposure index (BEI) may yield valuable information.
  • Safe exposure levels: Large proportions of many organic solvents are removed unchanged by means of exhalation; however, metabolism of the fraction that is absorbed often yields a water-soluble conjugate that is excreted mainly in the urine. Urinary or biliary excretion of the unchanged compound or metabolite is also common. These compounds are often measured in the urine and are the basis for BEIs. The levels of the metabolite or urinary compound are correlated with an exposure that is thought to be safe for a worker for 8 hours a day, 5 days a week. The ACGIH publishes these indices, which are only guidelines.[24] They are not enforceable by law (see Table 2 below). Monitoring is often impossible because exposure may have occurred in the distant past, or a specimen may be unobtainable.

Table 2. Exposure levels Believed Safe for Workers (Open Table in a new window)

CompoundUrineBloodExpired Air
AcetoneAcetone, formic acid 100 mg/LAcetoneAcetone
BenzeneTotal phenol 50 mg/g at the end of the shift, trans-trans- muconic acidBenzeneBenzene before shift, 0.08 ppm; end exhaled, 0.12 ppm
Carbon disulfide2-TTCA 5 mg/g*Carbon disulfideCarbon disulfide
ETONoneNoneNone
N- hexane2,5-hexanediol 5 mg/g at the end of the shift, 2-hexanol, total metabolitesN- hexaneN- hexane
Hydrogen sulfideNoneNoneNone
MethaneNoneNoneNone
Methyl mercaptanNoneNoneNone
MethanolFormic acid 80 mg/g at the start of the work week, methanol 15 mg/g at the end of the shiftNoneMethanol
Methyl-N- butyl ketoneNone2,5-hexane dioneNone
Methylene chlorideNoneMeCl2MeCl2
OrganochlorineNoneNoneNone
OrganophosphatesNoneNoneNone
PCEPCE, trichloroacetic acidPCE 1 mg/LPCE 10 ppm before the last shift of the week
StyreneEnd of the shift: mandelic acid (MA) 800 mg, phenylglyoxylic acid (PGA) 240 mg/g)



Before shift: MA 300 mg/g or PGA 100 mg/g



Styrene 0.02 mg/L at the start of the shift, 0.55 mg/L at the end of the shiftNone
TolueneHippuric acidTolueneToluene
1,1,1-Trichlorethane (methyl chloroform)TCA 10 mg/L at the end of the work week; total trichloroethanol at the end of the shift and at the end of the work week, 30 mg/L Total trichloroethanol 1 mg/LMethyl chloroform 40 ppm before the last shift of the work week
TCETCE, TCA 100 mg/g at the end of the work week or TCA plus trichloroethanol 300 mg/gTCE at the end of the work week 4 mg/LTCE
Vinyl chlorideNoneNoneNone
XyleneMethylhippuric acid 1.5 g/g at the end of the shiftXyleneXylene
* TTCA - 2-thiothiazolidine 4-carboxylic acid.

See the list below:

  • Formal standards: Industrial hygiene data are important to consider in setting standards for occupational settings. Industrial hygienists may take samples of air or other media to determine potential exposure.
    • In the United States, OSHA is the regulatory body that publishes and enforces standards or PELs for 8-hour-per-day, 5-day-per-week exposure.
    • NIOSH is the section of the Centers for Disease Control and Prevention (CDC) that performs research and publishes recommended exposure limits (RELs) that may be more conservative than OSHA's limits.[25]
    • The ACGIH publishes recommended TLVs that often are even more conservative than other standards.
    • The US Environmental Protection Agency (EPA) monitors ambient air and drinking water and sets standards for lifetime and shorter-term environmental exposures.
    • Individual states often set standards that are at or below EPA or OSHA standards.
  • Risk assessment: Risk assessment takes into account a data point and assumes toxicologic properties and chemical characteristics and models to determine potential exposure. This statistical method is used to develop exposure measurements to which regulations and recommended standards are compared. This method can be used to determine whether an exposure is likely to lead to health effects. Table 3 lists limits (eg, PELs, recommended exposure limits [RELs], and TLVs) from several agencies (eg, OSHA, NIOSH, and ACGIH) for specific organic solvents.

Table 3. Recommended Exposure Limits, Organic Solvents (Open Table in a new window)

Compoundppm, mg/m,3
OSHA PEL as TWAsNIOSH REL as TWAs, IDLHACGIH TLV, STEL
Acetone1000 (2400)250 (590), 2500750 (1780) ceiling, 1000 (2380)
Acrylamide0.3(0.03), 60 level for carcinogenicityNone
Benzene10, 25 ceiling, 50 for 10 min0.1, STEL 1, 50010 (32)
Carbon disulfide20, 30, 100 for 30 min1 (3), 10 STEL (30), 50010 (31)
ETO < 0.1, < 0.18, 5 ceiling, 8001 (1.8)
N- hexane500 (1800)50 (180), 110050 (176)
Hydrogen sulfide20 ceiling, 50 for 10 min once only10 ceiling, (15) for 10 min, 100None
Methyl mercaptan10 ceiling (20)0.5 ceiling, (1) for 15 min, 150None
Methanol200 (260)200 (260), 250 STEL (325), 6000262 (200), 328 (250)
Methyl-n- butyl ketone100 (410)None5 (20)
Methylene chloride25, 15 STEL for 15 min2300 level for carcinogenicity50 (174) ceiling
Perchloroethylene100, 200 ceiling, 300 for 5 min in 3 h150 level for carcinogenicity25 (170), 100 (685)
Styrene100, 200 ceiling, 600 for 5 min in 3 h50 (215), 100 ST (425), 70050 (213), 100 (428)
Toluene200, 300, 500 for 10 min100 (375), 150 STEL (560), 50050 (188)
1,1,1-Trichlorethane (methyl chloroform)350 (1900)Ceiling 350 (1900) for 15 min, 700350 (1910), 450 (2460)
Trichloroethylene100, 200 ceiling, 300 for 5 min in 2 h1000 level for carcinogenicity50 (269), 100 (1070)
Vinyl chloride1, 5 for 15 minNot determinedNone
Xylene100 (435)100 (435), 150 STEL (655)100 (434),150 (651)
Abbreviations—ACGIH = American Congress of Governmental Industrial Hygienists, IDLH = Immediately dangerous to life or health; NIOSH = National Institute for Occupational Safety and Health, OSHA = Occupational Safety and Health Administration, PEL = permissible exposure limit, REL = recommended exposure limit; STEL = short-term exposure limit; TWA = time-weighted average.
Next

Imaging Studies

See the list below:

  • CT, MRI, positron emission tomography (PET), and single-photon emission CT (SPECT) have been used to evaluate patients with organic solvent neurotoxicity, but no specific abnormalities are consistently demonstrated. MRI and CT have been used to differentiate encephalopathy due to organic solvent exposure from other causes of dementia or neurologic diseases (eg, normal-pressure hydrocephalus, multiple-infarct dementia, Alzheimer disease, multiple sclerosis, many others). Although images are often normal, many demonstrate focal abnormalities.
    • CT has been used to investigate the sequelae of chronic recreational inhalation of organic solvents consisting mainly of toluene.
      • In one study, 8 of 9 subjects had evidence of diffuse cerebellar and cerebral atrophy. Another study revealed that impairment on examination was correlated with CT findings. Cerebral atrophy was noted on CT scans in 5 of 6 workers after 6-27 years of occupational exposure to styrene vapor. In 1990, Aaserud demonstrated that 13 of 16 workers with long-term exposure to carbon disulfide in the viscose rayon industry had cerebral atrophy on CT scans.[26]
      • A 26-year-old woman presented with altered mental status 36 hours after ingesting methanol. She reported blurred vision then nausea and vomiting. CT scanning revealed mild cerebral edema on admission, but 48 hours later, scans revealed hypoattenuations in the putamen and in the peripheral white matter.[27]
    • MRI has also been applied to examine patients exposed to organic solvents.
      • MRI revealed olivopontocerebellar atrophy in a worker exposed to carbon disulfide for 30 years. MRI demonstrated mild cortical atrophy in a patient exposed to PCE for 30 years. Another study showed that increased signal intensity periventricular white matter on T2-weighted images was significantly correlated with neuropsychologic deficits.
      • MRI revealed global symmetrical volume loss involving white matter more than gray matter in a 57-year-old painter exposed to mixed organic solvents for 30 years. Eight years earlier, his brain CT scans had been normal.[5]
      • A Turkish medical journal published a case series of 4 patients who chronically abused thinner containing toluene. White-matter lesions were noted in 46%. These lesions began in the deep periventricular white matter and spread to the peripheral white matter, causing the loss of gray matter–white matter differentiation with continued abuse. The deposition of iron due to demyelination and axonal loss is the most probably mechanism for the thalamic hypointensity found in solvent abusers.[28]
      • A 40-year-old experimental physicist noticed a tremor in her right hand when she was writing. Her work was performing research on the optical properties of mixed single crystals that she thinned by etching them with bromine diluted in methanol. She did not use appropriate personal protection, but had no episodes of acute intoxication. The initial diagnosis was hemiparkinsonism, which became bilateral. T2-weighted MRI revealed bright, bilateral foci in the subcortical white matter near the left basal ganglia and in the right occipital region. Long tract signs were noted with bilateral hyperreflexia. Levodopa provided a partial benefit, and dystonia was noted with the peak dose. This case illustrated a delayed neurotoxic effect of a long-term exposure to methanol.[29]
    • Pneumoencephalography was performed in the past. Brain atrophy was noted in 64% of 37 patients undergoing pneumoencephalography in a Scandinavian study. Slight asymmetric central atrophy and slight local cortical atrophy were the most common findings. Pneumoencephalography is no longer performed.
    • SPECT was used to evaluate chronic occupational exposure.[30] It increased the sensitivity of detecting CNS abnormalities. SPECT findings were abnormal in 31 of 33 workers who developed clinical toxic encephalopathy. The most frequent abnormalities were noted in the temporal lobes, frontal lobes, basal ganglia, and thalamus. MRI demonstrated abnormal findings in 28% of patients.
Previous
Next

Other Tests

See the list below:

  • Neurophysiologic testing: EMG and NCS abnormalities have been demonstrated in individuals exposed to ETO, carbon disulfide, and mixed solvents (including xylene, TCE, PCE, toluene, and styrene, among others). Evidence of a mixed sensorimotor neuropathy has been found in many studies. Some have demonstrated a dose response when the exposure dose was compared with physiologic abnormalities. Other population studies revealed inconsistent results.
    • Gross et al reported 4 cases of peripheral neuropathy in workers who operated a leaky ETO sterilizer. Three had abnormal NCS and/or EMG results. The findings of muscle action potentials with decreased amplitude, signs of denervation, and moderately decreased conduction velocities were consistent with an axonal degenerative type of neuropathy.[31] Studies have revealed similar findings. Exposures varied in intensity and duration.
    • Viscose rayon workers examined 10 years after their exposure to carbon disulfide ceased had EMG and/or NCS findings suggestive of permanent axonal neuropathy. About 67% had evidence of neuropathy. In 1993, Ruijten et al performed a second study of the same workers, and exposed workers had abnormal motor NCSs of the peroneal nerve and abnormal sensory NCSs in the hand and arm segments of the median nerve and ulnar nerve and in the sural nerve.[32] , Johnson et al noted substantial abnormalities in sural sensory NCSs and peroneal motor NCSs in 156 male viscose rayon workers compared with control subjects. These changes were related in a dose-response manner to the workers' cumulative exposure to carbon disulfide.[33]
    • Scandinavian investigators assessed 87 patients with chronic solvent intoxication after occupational exposure. Abnormal EMG and/or NCS results were observed in 62% on the first evaluation, and in 74% on second evaluation 3-9 years later. Fibrillations were noted in 54% on initial examination and in 61% on reexamination. Exposures were to TCE, PCE, both, or other mixed solvents. Other populations of workers also had EMG and/or NCV abnormalities. The authors found a high percentage of slow motor and sensory conduction velocities and/or prolonged motor distal latencies in car painters but none in nonexposed controls subjects.
    • In another study, 28 exposed painters were compared with age-matched subjects and were found to have significantly prolonged refractory periods in lower-extremity motor and sensory nerves.
    • A high prevalence of slowed conduction velocity in the radial and peroneal nerves was observed in 490 workers exposed to styrene. A consistent decrement in peripheral-nerve conduction velocity was noted with duration of occupational exposure.
    • Mild sensory NCS deficits were found in men exposed to various levels of styrene in 4 Canadian factories.
    • A 55-year-old woman developed Guillain-Barré syndrome with nephrotic syndrome after exposure to an occupational solvent containing acetone.[34]
    • Croatian researchers studied the effects of mixed solvents in the painting and lacquer industries on the PNS. They assessed the BEIs for toluene (hippuric acid) and xylene (methyl hippuric acid), as well as sensory and motor conduction velocities for the radial and tibial nerves along with the distal tibial motor latency. Slowing was observed in workers and worse than findings in control subjects, with a clear trend of further deterioration with prolonged exposure. Subjects had more than 2 months of exposure and had no previous neurologic conditions or significant medical history.[35]
    • Environmental exposure has been implicated in EMG and NCS abnormalities. Three populations with exposure to organic solvents, including TCE, in well water were reported by to have evidence of subclinical peripheral neuropathy.[36] Blink-reflex testing showed considerable abnormalities, which was evidence for trigeminal neuropathy attributed to TCE toxicity. Abnormal blink-reflex testing has also been reported in populations with occupational TCE exposures.
    • Investigators in field studies have used quantitative sensory testing, such as vibrometry and current perception threshold (CPT) testing. Vibrometry is used to assess large-fiber function by simulating vibration. CPT is used to assess all 3 populations of nerve fibers: large myelinated, small myelinated, and small unmyelinated.
  • Neuropsychological testing: Many investigators from many international institutions have conducted neuropsychological testing in subjects with long-term occupational and environmental exposures to organic solvents from various industries. Some have performed behavioral testing after short-term experimental exposures. Different test batteries have been used, depending on the investigator, exposure, and sample size.
    • Testing may be performed to assess for neurologic dysfunction, consistency with deficits reported from specific exposures, or clinical progress (ie, comparison with previous findings in an individual).
    • Neurobehavioral effects of exposure to neurotoxins are characterized by impairments in 1 or more of the following functional areas: intelligence, attention, executive function, fluency, motor abilities, visuospatial skills, learning and short-term memory, and mood and adjustment. Variables, including age and maturity at the time of exposure, and individual subject variables, such as cognitive skills, preceding deficits, education, and socioeconomic status, are important to consider in assessing a subject with chemical exposure.
    • Neuropsychological studies of persons with the following occupations have been conducted:
      • House and car spray painters
      • Viscose rayon workers
      • Hospital and machine sterilization workers
      • Hospital workers
      • Histology technicians
      • Screen printers
      • Rotogravure printers
      • Ammunitions plant workers
      • Floor layers
      • Sewer workers
      • Hazardous waste workers
      • Microelectronics workers
      • Automotive carburetor plant workers
      • Varnishing industry workers
      • Dry cleaning workers
      • Chemical cleaning workers
      • Domestic appliance manufacturing workers
      • Fiberglass boat builders
      • Polyester and polyvinyl chloride factory workers
      • Plastics workers
      • Dockyard workers
      • Metal degreasers
  • Exposures to mixed solvents, as well as exposures to carbon disulfide, ETO, styrene, xylene, toluene, TCE, PCE, and vinyl chloride, have been investigated.
    • Both positive and negative findings are reported for many populations. Studies vary widely in exposure intensity and duration and in epidemiologic study design (eg, sample size, sensitivity and specificity of testing batteries, ages, exclusion and inclusion criteria, comparability of control populations).
    • Case study:  A 57-year-old painter with more than 30 years of mixed solvent exposure had stopped working 4 years before presentation. Impairments were noted on tests of verbal and nonverbal memory, attention, execution, and visuomotor coordination. A second test, including the Boston Naming test, revealed normal language and spontaneous speech. Persistent static deficits were deemed not consistent with Alzheimer disease or multiinfarct dementia.[5]
    • Case study:  In 1 study, 180 shipyard painters and 60 reference workers completed questionnaires about their symptoms and history. Exposure was estimated by industrial-hygiene measurements of the ambient air. Results for symbol-digit substitution and finger-tapping speed for both the dominant and the nondominant hand were affected. The duration of work was also associated with abnormal results.[37]
    • Case study:  In another study, 55 chronic solvent abusers underwent MRI and neuropsychological testing, and their results were compared with those who abused other drugs, such as cocaine and alcohol. Both groups had abnormal MRIs, but the group abusing solvents had more abnormalities than the other. They also performed more poorly than the other group in terms of working memory and executive functions. No clear dose response was noted between solvent exposure and neuropsychological abnormalities, but a strong dose-response relationship was observed in the presence of MRI abnormalities. MRI may be more useful than other tools in evaluating these types of patients.[38]
  • Electroencephalography (EEG): Abnormalities have been demonstrated in many populations exposed to organic solvents.
    • Case study:  Excessive theta activity was noted in a patient exposed to mixed solvents for more than 30 years who had memory difficulties, disorientation, irritability and insomnia. Sharp activity of low-to-medium voltage was noted in the posterior occipital area. A moderate amount of fast beta activity was superimposed over the background activity. About 4 years after the patient stopped working, his condition had not substantially progressed.[5]
    • Case study: Acute effects of xylene exposure were assessed in 9 volunteers with short-term exposure of < 400 ppm. Exposure increased the dominant alpha frequency and the alpha percentage during the early phase of exposure and counteracted the effect of exercise. These effects were deemed minor and not deleterious. About 65% of 107 patients with solvent poisoning after long-standing occupational exposure had abnormal EEGs. Excessive beta activity was noted in 54%. Focal slow-wave activity was correlated with inaccurate hand movements detected by using a motor test. Among patients assessed by the same author, 67% had abnormal EEG findings, predominantly diffuse slow-wave activity, on the first examination; on a second examination, 47% had abnormalities (more paroxysmal abnormalities than before).
    • Case study: Thirty-three styrene-exposed workers were evaluated with EEG. Three groups of exposure were assessed: at the TLV, clearly below the TLV, and clearly above the TLV. EEGs of these groups, of nonexposed individuals, and of those with exposure to mixed organic solvents were compared. Increased diffuse slow activity was seen in some of the styrene-exposed group and in many for the mixed-exposure group. No clear relationship to exposure was noted. An increased occurrence of fast activity in central and precentral areas was noted in the groups. Twenty-three of 98 male workers exposed to styrene in the reinforced plastics industry had abnormal EEGs. This was deemed a high prevalence.
  • Other tests to consider
    • Color-vision testing by using the Lanthony D-15 and the FM-100 tests has been useful in exposed populations. Long-term occupational exposure is associated with blue-yellow color loss (dyschromatopsia) that progresses to red-green color loss with continued exposure. Styrene, carbon disulfide, n -hexane, PCE, and other solvents are positively associated with these effects in populations working in many industries: microelectronics, paint manufacturing, airline mechanic, dry cleaning, plastics, shipbuilding, viscose rayon, adhesive bandage processing, and vegetable-oil extraction. Authors have postulated that subclinical findings may herald more drastic nervous system dysfunction.[39]
    • Color fundal photography and ophthalmoscopy have been used to assess specific populations. In 1978, Sugimoto et al reported the association between retinopathy and carbon disulfide.[40] In 1983, Karai et al used fluorescein angiography to further evaluate populations from the viscose-rayon industry.[41]
    • Oculomotor and cerebellar function have also been studied in exposed populations. Electronystagmography (ENG) eye-movement testing and body-sway posturography have been some modalities used. These studies are performed mainly in subjects acutely exposed to styrene, xylene, and toluene. Both positive and negative associations have been found.
    • Case reports describe subjects with visual-field abnormalities. A 26-year-old man with high-dose acute occupational exposure to TCE had constricted visual fields. A 20-year-old man who intentionally abused toluene had reduced and constricted visual fields. Both patients recovered after many months. In 2 workers in a viscose rayon factory, carbon disulfide lead to visual-field narrowing and enlargement of the blind spot.
    • Evoked potentials have been used to assess many populations. Positive associations are reported in workers at printing presses workers and rotogravure printers, manufacturers of adhesive bandage, and vegetable-old extractors (n -hexane exposure), as well as in volunteers with short-term PCE exposure.
    • Contrast sensitivity and critical flicker fusion are included in many test batteries to assess exposed subjects. Positive associations are reported for contrast sensitivity with mixed solvent exposures in the microelectronics industry.
    • Tremometer has been used to assess populations with exposures to carbon disulfide.
  • Neuropathologic testing: Sural-nerve biopsy was reviewed in a number of studies of subjects exposed to ETO or carbon disulfide. Findings were consistent with axonal neuropathy, Wallerian degeneration, and some nerve-fiber regeneration.
    • In 1983, Kuzuhara et al noted mild degeneration of the myelin sheath in 2 workers.[42]
    • In 1985, Gottfried et al described the morphology of carbon disulfide neurotoxicity in peripheral nerves of rats. Experimental application of TCE to rat trigeminal nerves led to focal myelin and axon loss.[43]
    • Findings from few brain pathology specimens of patients with organic solvent exposure have been reported.
Previous
 
 
Contributor Information and Disclosures
Author

Jonathan S Rutchik, MD, MPH Associate Clinical Professor, Division of Occupational Medicine, Department of Medicine, University of California, San Francisco, School of Medicine; Neurology, Environmental and Occupational Medicine Associates (www.neoma.com)

Jonathan S Rutchik, MD, MPH is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, International Parkinson and Movement Disorder Society, Society of Toxicology, Western Occupational and Environmental Medical Association, American College of Occupational and Environmental Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Glenn Lopate, MD Associate Professor, Department of Neurology, Division of Neuromuscular Diseases, Washington University School of Medicine; Consulting Staff, Department of Neurology, Barnes-Jewish Hospital

Glenn Lopate, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, Phi Beta Kappa

Disclosure: Nothing to disclose.

Chief Editor

Tarakad S Ramachandran, MBBS, MBA, MPH, FAAN, FACP, FAHA, FRCP, FRCPC, FRS, LRCP, MRCP, MRCS Professor Emeritus of Neurology and Psychiatry, Clinical Professor of Medicine, Clinical Professor of Family Medicine, Clinical Professor of Neurosurgery, State University of New York Upstate Medical University; Neuroscience Director, Department of Neurology, Crouse Irving Memorial Hospital

Tarakad S Ramachandran, MBBS, MBA, MPH, FAAN, FACP, FAHA, FRCP, FRCPC, FRS, LRCP, MRCP, MRCS is a member of the following medical societies: American College of International Physicians, American Heart Association, American Stroke Association, American Academy of Neurology, American Academy of Pain Medicine, American College of Forensic Examiners Institute, National Association of Managed Care Physicians, American College of Physicians, Royal College of Physicians, Royal College of Physicians and Surgeons of Canada, Royal College of Surgeons of England, Royal Society of Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Roberta J Seidman, MD Associate Professor of Clinical Pathology, Stony Brook University; Director of Neuropathology, Department of Pathology, Stony Brook University Medical Center

Roberta J Seidman, MD is a member of the following medical societies: American Academy of Neurology, Suffolk County Society of Pathologists, New York Association of Neuropathologists (The Neuroplex), American Association of Neuropathologists

Disclosure: Nothing to disclose.

References
  1. Orsi L, Monnereau A, Dananche B, Berthou C, Fenaux P, Marit G, et al. Occupational exposure to organic solvents and lymphoid neoplasms in men: results of a French case-control study. Occup Environ Med. 2010 Oct. 67(10):664-72. [Medline].

  2. Gargouri I, Khadhraoui M, Nisse C, Leroyer A, Masmoudi ML, Frimat P, et al. A case study on co-exposure to a mixture of organic solvents in a Tunisian adhesive-producing company. J Occup Med Toxicol. 2011 Nov 14. 6:28. [Medline]. [Full Text].

  3. Fatal exposure to methylene chloride among bathtub refinishers - United States, 2000-2011. MMWR Morb Mortal Wkly Rep. 2012 Feb 24. 61(7):119-22. [Medline].

  4. Page EH, Pajeau AK, Arnold TC, et al. Peripheral neuropathy in workers exposed to nitromethane. Am J Ind Med. 2001 Jul. 40(1):107-13. [Medline].

  5. Feldman RG, Ratner MH, Ptak T. Chronic toxic encephalopathy in a painter exposed to mixed solvents. Environ Health Perspect. 1999 May. 107(5):417-22. [Medline].

  6. Kelsall H, Macdonell R, Sim M, et al. Neurological status of Australian veterans of the 1991 Gulf War and the effectof medical and chemical exposures. Int J Epidemiol. 2005 Aug. 34(4):810-9. [Medline].

  7. Longstreth WT. Central nervous system disorders, neurological and psychological disorders. Rosenstock L, Cullen MR, eds. Textbook of Clinical, Occupational and Environmental Medicine. Philadelphia, PA: WB Saunders; 1994.

  8. LaDou J. Approach to the diagnosis of the occupational illness. LaDou J, ed. Occupational and Environmental Medicine. Lange Medical. 2nd ed. New York, NY: McGraw-Hill Professional; 1997.

  9. Hanley KW, Petersen MR, Cheever KL, Luo L. Bromide and N-acetyl-S-(n-propyl)-L-cysteine in urine from workers exposed to 1-bromopropane solvents from vapor degreasing or adhesive manufacturing. Int Arch Occup Environ Health. 2010 Jun. 83(5):571-84. [Medline].

  10. Hanley KW, Petersen MR, Cheever KL, Luo L. N-acetyl-S-(n-propyl)-l-cysteine in urine from workers exposed to 1-bromopropane in foam cushion spray adhesives. Ann Occup Hyg. 2009 Oct. 53(7):759-69. [Medline].

  11. Majersik JJ, Caravati EM, Steffens JD. Severe neurotoxicity associated with exposure to the solvent 1-bromopropane (n-propyl bromide). Clin Toxicol (Phila). 2007. 45(3):270-6. [Medline].

  12. Sclar G. Encephalomyeloradiculoneuropathy following exposure to an industrial solvent. Clin Neurol Neurosurg. 1999 Sep. 101(3):199-202. [Medline].

  13. Pezzoli G, Strada O, Silani V, Zecchinelli A, Perbellini L, Javoy-Agid F. Clinical and pathological features in hydrocarbon-induced parkinsonism. Ann Neurol. 1996 Dec. 40(6):922-5. [Medline].

  14. McCrank E, Rabheru K. Four cases of progressive supranuclear palsy in patients exposed to organic solvents. Can J Psychiatry. 1989 Dec. 34(9):934-6. [Medline].

  15. Tetrud JW, Langston JW, Irwin I, Snow B. Parkinsonism caused by petroleum waste ingestion. Neurology. 1994 Jun. 44(6):1051-4. [Medline].

  16. Uitti RJ, Snow BJ, Shinotoh H, Vingerhoets FJ, Hayward M, Hashimoto S. Parkinsonism induced by solvent abuse. Ann Neurol. 1994 May. 35(5):616-9. [Medline].

  17. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983 Feb 25. 219(4587):979-80. [Medline].

  18. Gash DM, Rutland K, Hudson NL, Sullivan PG, Bing G, Cass WA, et al. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol. 2008 Feb. 63(2):184-92. [Medline].

  19. Guehl D, Bezard E, Dovero S, Boraud T, Bioulac B, Gross C. Trichloroethylene and parkinsonism: a human and experimental observation. Eur J Neurol. 1999 Sep. 6(5):609-11. [Medline].

  20. Kochen W. the endogenous formation of highly chlorinated tetr-beta- carbolines as a possible causative mechanism in idiopathic Parkinson's disease. Advances in Experimental Medicine and Biology. 2003. 527:253-63.

  21. Liu M, Choi DY, Hunter RL, Pandya JD, Cass WA, Sullivan PG. Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J Neurochem. 2010 Feb. 112(3):773-83. [Medline].

  22. Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS. Solvent exposures and Parkinson disease risk in twins. Ann Neurol. 2012 Jun. 71(6):776-84. [Medline].

  23. Mattia CJ, Adams JD Jr, Bondy SC. Free radical induction in the brain and liver by products of toluene catabolism. Biochem Pharmacol. 1993 Jul 6. 46(1):103-10. [Medline].

  24. American Conference of Governmental Industrial Hygienists (ACGIH). American Conference of Governmental Industrial Hygienists. Threshold Limit Values and Biological Exposure Indices. 1999.

  25. Current Intelligence Bulletin 48. Organic solvent neurotoxicity. March 31, 1987. National Institute for Occupational Safety and Health (NIOSH). Available at http://www.cdc.gov/niosh/87104_48.html..

  26. Aaserud O, Hommeren OJ, Tvedt B, Nakstad P, Mowé G, Efskind J, et al. Carbon disulfide exposure and neurotoxic sequelae among viscose rayon workers. Am J Ind Med. 1990. 18(1):25-37. [Medline].

  27. Fontenot AP, Pelak VS. Development of neurologic symptoms in a 26-year-old woman following recovery from methanol intoxication. Chest. 2002 Oct. 122(4):1436-9. [Medline].

  28. Aydin K, Sencer S, Demir T, Ogel K, Tunaci A, Minareci O. Cranial MR findings in chronic toluene abuse by inhalation. AJNR Am J Neuroradiol. 2002 Aug. 23(7):1173-9. [Medline].

  29. Finkelstein Y, Vardi J. Progressive parkinsonism in a young experimental physicist following long-term exposure to methanol. Neurotoxicology. 2002 Oct. 23(4-5):521-5. [Medline].

  30. Callender TJ, Morrow L, Subramanian K, Duhon D, Ristovv M. Three-dimensional brain metabolic imaging in patients with toxic encephalopathy. Environ Res. 1993 Feb. 60(2):295-319. [Medline].

  31. Gross JA, Haas ML, Swift TR. Ethylene oxide neurotoxicity: report of four cases and review of the literature. Neurology. 1979 Jul. 29(7):978-83. [Medline].

  32. Ruijten MW, Sallé HJ, Verberk MM. Verification of effects on the nervous system of low level occupational exposure to CS2. Br J Ind Med. 1993 Apr. 50(4):301-7. [Medline]. [Full Text].

  33. Johnson BL, Boyd J, Burg JR, Lee ST, Xintaras C, Albright BE. Effects on the peripheral nervous system of workers' exposure to carbon disulfide. Neurotoxicology. 1983 Spring. 4(1):53-65. [Medline].

  34. Chen JK, Wu MS, Yang CW, Huang JY, Hsu PY, Lin CL, et al. Guillain-Barré syndrome associated with minimal change glomerulopathy and tubular dysfunction - related to acetone-based organic solvent?. Am J Nephrol. 2002 Sep-Dec. 22(5-6):560-5. [Medline].

  35. Jovanic JM, Jovanovich MM, Spasic MJ. Peripheral nerve conduction study in workers exposed to a mixture of organic solvents in the paint and lacquer industry. Croat Med J. 2004. 45:769-74.

  36. Feldman RG. The Vulnerable Brain and Environmental Risks. Isaacson RL, Jensen KF, eds. Neurotoxic effects of trichloroethylene in drinking water. New York, NY: Plenum; 1994. Vol 3: Toxins in Air and Water.

  37. Lee CR, Jeong KS, Kim Y, Yoo CI, Lee JH, Choi YH. Neurobehavioral changes of shipyard painters exposed to mixed organic solvents. Ind Health. 2005 Apr. 43(2):320-6. [Medline].

  38. Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol. 2002. 40(1):21-34. [Medline].

  39. Lacerda EM, Lima MG, Rodrigues AR, Teixeira CE, de Lima LJ, Ventura DF, et al. Psychophysical evaluation of achromatic and chromatic vision of workers chronically exposed to organic solvents. J Environ Public Health. 2012. 2012:784390. [Medline]. [Full Text].

  40. Sugimoto K, Goto S, Kanda S, Taniguchi H, Nakamura K, Baba T. Studies on angiopathy due to carbon disulfide. Retinopathy and index of exposure dosages. Scand J Work Environ Health. 1978 Jun. 4(2):151-8. [Medline].

  41. Karai I, Sugimoto K, Goto S. A case comparison study of carbon disulfide retinopathy and diabetic retinopathy using fluorescein fundus angiography. Acta Ophthalmol (Copenh). 1983 Dec. 61(6):1074-86. [Medline].

  42. Kuzuhara S, Kanazawa I, Nakanishi T, Egashira T. Ethylene oxide polyneuropathy. Neurology. 1983 Mar. 33(3):377-80. [Medline].

  43. Gottfried MR, Graham DG, Morgan M, Casey HW, Bus JS. The morphology of carbon disulfide neurotoxicity. Neurotoxicology. 1985 Winter. 6(4):89-96. [Medline].

  44. Vaktskjold A, Talykova LV, Nieboer E. Congenital anomalies in newborns to women employed in jobs with frequent exposure to organic solvents--a register-based prospective study. BMC Pregnancy Childbirth. 2011 Oct 27. 11:83. [Medline]. [Full Text].

  45. Iregren A. Effects on human performance from acute and chronic exposure to organic solvents: a short review. Toxicology. 1988 May. 49(2-3):349-58. [Medline].

  46. Bolla K, Roca R. Occupational Neurology and Clinical Neurotoxicology. Bleeker ML, Hansen JA, eds. Neuropsychiatric sequelae of occupational exposure to neurotoxins. Baltimore, MD: Lippincott Williams and Wilkins; 1994.

  47. Cassitto MG. Vinken and Bruyn's Handbook of Clinical Neurology Part I. de Wolff FA, ed. Organic solvents and the nervous system. Amsterdam, the Netherlands: Elsevier; 1994. Intoxications of the Nervous System.

  48. Dick RB. Handbook of Neurotoxicology. Chang LW, ed. Neurobehavioral assessment of occupationally relevant solvents and chemicals in humans. New York, NY: Marcel Dekker; 1995.

  49. Rosenberg NL. Occupational and Environmental Neurology. Rosenberg NL, ed. Neurotoxicity of organic solvents. Boston, MA: Butterworth-Heinman; 1995.

  50. White RF, Proctor SP. Approaches and Methods. Chang L, ed. Clinico-neuropsychological assessment methods in behavioral neurotoxicology. San Diego, CA: Academic Press; 1995: Neurotoxicology.

  51. Fiedler N. Neuropsychological approaches for the detection and evaluation of toxic symptoms. Environ Health Perspect. 1996 Apr. 104 Suppl 2:239-45. [Medline]. [Full Text].

  52. . Centers for Disease Control and Prevention. n-Hexane-related peripheral neuropathy among automotive technicians--California, 1999-2000. MMWR Morb Mortal Wkly Rep. 2001 Nov 16. 50(45):1011-3. [Medline].

  53. 3rd Industrial and Environmental Neurology Congress. Prague 25-28th June 1979 [abstracts]. Act Nerv Super (Praha). 1979 Dec. 21(4):244-303. [Medline].

  54. Altmann L, Böttger A, Wiegand H. Neurophysiological and psychophysical measurements reveal effects of acute low-level organic solvent exposure in humans. Int Arch Occup Environ Health. 1990. 62(7):493-9. [Medline].

  55. Altmann L, Neuhann HF, Krämer U, Witten J, Jermann E. Neurobehavioral and neurophysiological outcome of chronic low-level tetrachloroethene exposure measured in neighborhoods of dry cleaning shops. Environ Res. 1995 May. 69(2):83-9. [Medline].

  56. Astrand I. Uptake of solvents in the blood and tissues of man. A review. Scand J Work Environ Health. 1975 Dec. 1(4):199-218. [Medline].

  57. Barret L, Torch S, Usson Y, Gonthier B, Saxod R. A morphometric evaluation of the effects of trichloroethylene and dichloroacetylene on the rat mental nerve. Preliminary results. Neurosci Lett. 1991 Oct 14. 131(2):141-44. [Medline].

  58. Behese F, Buchtal F. Alcoholic neuropathy: clinical, electrophysiological and biopsy findings. Annals of Neurology. 1977. 2:95.

  59. Broadwell DK, Darcey DJ, Hudnell HK, Otto DA, Boyes WK. Work-site clinical and neurobehavioral assessment of solvent-exposed microelectronics workers. Am J Ind Med. 1995 May. 27(5):677-98. [Medline].

  60. Cavalleri A, Gobba F, Paltrinieri M, Fantuzzi G, Righi E, Aggazzotti G. Perchloroethylene exposure can induce colour vision loss. Neurosci Lett. 1994 Sep 26. 179(1-2):162-6. [Medline].

  61. Cherry N, Gautrin D. Neurotoxic effects of styrene: further evidence. Br J Ind Med. 1990 Jan. 47(1):29-37. [Medline]. [Full Text].

  62. Corsi G, Maestrelli P, Picotti G, Manzoni S, Negrin P. Chronic peripheral neuropathy in workers with previous exposure to carbon disulphide. Br J Ind Med. 1983 May. 40(2):209-11. [Medline]. [Full Text].

  63. Eisenberg J, Ramsey J. Evaluation of 1-Bromopropane Use in Four New Jersey Commercial Dry Cleaning Facilities75-3111New Jersey Department of Health and Senior Services. Health Hazard Evaluation Report. 2010.

  64. Feldman RG. Neurotoxicology. Feldman RG. Recognizing the chemically exposed person and approach to diagnosis. Philadelphia, PA: Lippincott Raven; 1999.

  65. Feldman RG, Lessell S. Progress in Neuroophthalmology. Neuroophthalmological aspects of trichloroethylene intoxication. Brunette J, ed. Amsterdam, Netherlands: 1969.

  66. Feldman RG, Niles C, Proctor SP, Jabre J. Blink reflex measurement of effects of trichloroethylene exposure on the trigeminal nerve. Muscle Nerve. 1992 Apr. 15(4):490-5. [Medline].

  67. Filley CM, Heaton RK, Rosenberg NL. White matter dementia in chronic toluene abuse. Neurology. 1990 Mar. 40(3 Pt 1):532-4. [Medline].

  68. Fornazzari L, Wilkinson DA, Kapur BM, Carlen PL. Cerebellar, cortical and functional impairment in toluene abusers. Acta Neurol Scand. 1983 Jun. 67(6):319-29. [Medline].

  69. Freed DM, Kandel E. Long-term occupational exposure and the diagnosis of dementia. Neurotoxicology. 1988 Fall. 9(3):391-400. [Medline].

  70. Frumkin H. Multiple system atrophy following chronic carbon disulfide exposure. Environ Health Perspect. 1998 Sep. 106(9):611-3. [Medline]. [Full Text].

  71. Garnier R, Bédouin J, Pépin G, Gaillard Y. Coin-operated dry cleaning machines may be responsible for acute tetrachloroethylene poisoning: report of 26 cases including one death. J Toxicol Clin Toxicol. 1996. 34(2):191-7. [Medline].

  72. Gobba F, Galassi C, Imbriani M, Ghittori S, Candela S, Cavalleri A. Acquired dyschromatopsia among styrene-exposed workers. J Occup Med. 1991 Jul. 33(7):761-5. [Medline].

  73. Graham DG, Amarnath V, Valentine WM, Pyle SJ, Anthony DC. Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit Rev Toxicol. 1995. 25(2):91-112. [Medline].

  74. Herd PA, Martin HF. Effect of 1,1,1-trichloroethane on mitochondrial metabolism. Biochem Pharmacol. 1975 Jun 15. 24(11-12):1179-85. [Medline].

  75. Hormes JT, Filley CM, Rosenberg NL. Neurologic sequelae of chronic solvent vapor abuse. Neurology. 1986 May. 36(5):698-702. [Medline].

  76. Ichihara G, Li W, Shibata E, Ding X, Wang H, Liang Y, et al. Neurologic abnormalities in workers of a 1-bromopropane factory. Environ Health Perspect. 2004 Sep. 112(13):1319-25. [Medline]. [Full Text].

  77. Ikeda M. Public health problems of organic solvents. Toxicol Lett. 1992 Dec. 64-65 Spec No:191-201. [Medline].

  78. Juntunen J, Hernberg S, Eistola P, Hupli V. Exposure to industrial solvents and brain atrophy. A retrospective study of pneumoencephalographic findings among 37 patients with exposure to industrial solvents. Eur Neurol. 1980. 19(6):366-75. [Medline].

  79. Keane JR. Toluene optic neuropathy. Ann Neurol. 1978 Oct. 4(4):390. [Medline].

  80. Kyrklund T, Kjellstrand P, Haglid KG. Lipid composition and fatty acid pattern of the gerbil brain after exposure to perchloroethylene. Arch Toxicol. 1987 Jul. 60(5):397-400. [Medline].

  81. Landrigan PJ, Kominsky JR, Stein GF, Ruhe RL, Watanabe AS. Common-source community and industrial exposure to trichloroethylene. Arch Environ Health. 1987 Nov-Dec. 42(6):327-32. [Medline].

  82. Li W, Shibata E, Zhou Z, Ichihara S, Wang H, Wang Q. Dose-dependent neurologic abnormalities in workers exposed to 1-bromopropane. J Occup Environ Med. 2010 Aug. 52(8):769-77. [Medline].

  83. Lilis R, Lorimer WV, Diamond S, Selikoff IJ. Neurotoxicity of styrene in production and polymerization workers. Environ Res. 1978 Feb. 15(1):133-8. [Medline].

  84. Logue JN, Stroman RM, Reid D, Hayes CW, Sivarajah K. Investigation of potential health effects associated with well water chemical contamination in Londonderry Township, Pennsylvania, U.S.A. Arch Environ Health. 1985 May-Jun. 40(3):155-60. [Medline].

  85. Majersik JJ, Caravati EM, Steffens JD. Severe neurotoxicity associated with exposure to the solvent 1-bromopropane (n-propyl bromide). Clin Toxicol (Phila). 2007. 45(3):270-6. [Medline].

  86. Matsuoka M, Igisu H, Inoue N, Hori H, Tanaka I. Inhibition of creatine kinase activity by ethylene oxide. Br J Ind Med. 1990 Jan. 47(1):44-7. [Medline]. [Full Text].

  87. McKenna MJ, DiStefano V. Carbon disulfide. I. The metabolism of inhaled carbon disulfide in the rat. J Pharmacol Exp Ther. 1977 Aug. 202(2):245-52. [Medline].

  88. Mergler D, Blain L. Assessing color vision loss among solvent-exposed workers. Am J Ind Med. 1987. 12(2):195-203. [Medline].

  89. Mergler D, Huel G, Bowler R, Frenette B, Cone J. Visual dysfunction among former microelectronics assembly workers. Arch Environ Health. 1991 Nov-Dec. 46(6):326-34. [Medline].

  90. Monforte R, Estruch R, Valls-Solé J, Nicolás J, Villalta J, Urbano-Marquez A. Autonomic and peripheral neuropathies in patients with chronic alcoholism. A dose-related toxic effect of alcohol. Arch Neurol. 1995 Jan. 52(1):45-51. [Medline].

  91. Moslen MT, Reynolds ES, Szabo S. Enhancement of the metabolism and hepatotoxicity of trichloroethylene and perchloroethylene. Biochem Pharmacol. 1977 Mar 1. 26(5):369-75. [Medline].

  92. Patel JM, Harper C, Drew RT. The biotransformation of p-xylene to a toxic aldehyde. Drug Metab Dispos. 1978 Jul-Aug. 6(4):368-74. [Medline].

  93. Pezzoli G, Canesi M, Antonini A, Righini A, Perbellini L, Barichella M. Hydrocarbon exposure and Parkinson's disease. Neurology. 2000 Sep 12. 55(5):667-73. [Medline].

  94. Raitta C, Teir H, Tolonen M, Nurminen M, Helpiö E, Malmström S. Impaired color discrimination among viscose rayon workers exposed to carbon disulfide. J Occup Med. 1981 Mar. 23(3):189-92. [Medline].

  95. Raymond LW, Ford MD. Severe illness in furniture makers using a new glue: 1-bromopropane toxicity confounded by arsenic. J Occup Environ Med. 2007 Sep. 49(9):1009-19. [Medline].

  96. Rosenberg J, Cone J, Katz E. Occupational and Environmental Medicine. .LaDou J, ed. Solvents. Lange Medical 2nd ed. New York, NY: McGraw-Hill Professional; 1997.

  97. Rosén I, Haeger-Aronsen B, Rehnström S, Welinder H. Neurophysiological observations after chronic styrene exposure. Scand J Work Environ Health. 1978. 4 Suppl 2:184-94. [Medline].

  98. Ruijten MW, Hooisma J, Brons JT, Habets CE, Emmen HH, Muijser H. Neurobehavioral effects of long-term exposure to xylene and mixed organic solvents in shipyard spray painters. Neurotoxicology. 1994 Fall. 15(3):613-20. [Medline].

  99. Samukawa M, Ichihara G, Oka N, Kusunoki S. A case of severe neurotoxicity associated with exposure to 1-bromopropane, an alternative to ozone-depleting or global-warming solvents. Arch Intern Med. 2012 Sep 10. 172(16):1257-60. [Medline].

  100. Savic SM. Influence of carbon disulfide on the eye. Arch Environ Health. 1967 Feb. 14(2):325-6. [Medline].

  101. Schaumburg HH, Spencer PS. Environmental hydrocarbons produce degeneration in cat hypothalamus and optic tract. Science. 1978 Jan 13. 199(4325):199-200. [Medline].

  102. Schröder JM, Hoheneck M, Weis J, Deist H. Ethylene oxide polyneuropathy: clinical follow-up study with morphometric and electron microscopic findings in a sural nerve biopsy. J Neurol. 1985. 232(2):83-90. [Medline].

  103. Seppäläinen AM. Neurotoxicity of styrene in occupational and experimental exposure. Scand J Work Environ Health. 1978. 4 Suppl 2:181-3. [Medline].

  104. Seppäläinen AM, Antti-Poika M. Time course of electrophysiological findings for patients with solvent poisoning. A descriptive study. Scand J Work Environ Health. 1983 Feb. 9(1):15-24. [Medline].

  105. Seppäläinen AM, Husman K, Mårtenson C. Neurophysiological effects of long-term exposure to a mixture of organic solvents. Scand J Work Environ Health. 1978 Dec. 4(4):304-14. [Medline].

  106. Seppäläinen AM, Laine A, Salmi T, Verkkala E, Riihimäki V, Luukkonen R. Electroencephalographic findings during experimental human exposure to m-xylene. Arch Environ Health. 1991 Jan-Feb. 46(1):16-24. [Medline].

  107. Seppäläinen AM, Lindström K, Martelin T. Neurophysiological and psychological picture of solvent poisoning. Am J Ind Med. 1980. 1(1):31-42. [Medline].

  108. Seppäläinen AM, Raitta C, Huuskonen MS. n-Hexane-induced changes in visual evoked potentials and electroretinograms of industrial workers. Electroencephalogr Clin Neurophysiol. 1979 Oct. 47(4):492-8. [Medline].

  109. Snyder RS, Andrews LS. Klassen’sCasarett and Doull’s Toxicology. Toxic effects of solvents and vapors. 5th ed. McGraw-Hill: 1996.

  110. So Y. Occupational and Environmental Medicine. LaDou J, ed. Neurotoxicology. 2nd ed. Lange: 1997.

  111. St Clair MB, Anthony DC, Wikstrand CJ, Graham DG. Neurofilament protein crosslinking in gamma-diketone neuropathy: in vitro and in vivo studies using the seaworm myxicola infundibulum. Neurotoxicology. 1989 Winter. 10(4):743-56. [Medline].

  112. Stanosz S, Kuligowski D, Pieleszek A, Zuk E, Rzechula D, Chlubek D. Concentration of dopamine in plasma, activity of dopamine beta-hydroxylase in serum and urinary excretion of free catecholamines and vanillylmandelic acid in women chronically exposed to carbon disulphide. Int J Occup Med Environ Health. 1994. 7(3):257-61. [Medline].

  113. Suwanlaong K, Phanthumchinda K. Neurological manifestation of methyl bromide intoxication. J Med Assoc Thai. 2008 Mar. 91(3):421-6. [Medline].

  114. Urban P, Lukás E. Visual evoked potentials in rotogravure printers exposed to toluene. Br J Ind Med. 1990 Dec. 47(12):819-23. [Medline]. [Full Text].

  115. Vrca A, Bozicevic D, Karacic V, Fuchs R, Prpic-Majic D, Malinar M. Visual evoked potentials in individuals exposed to long-term low concentrations of toluene. Arch Toxicol. 1995. 69(5):337-40. [Medline].

  116. Wegman DH, Levy BS, Halperin WE. Occupational Health. Levy BS, Wegman DH, eds. Recognizing occupational disease. 3rd ed. Boston, MA: Little Brown & Company; 1994.

  117. Williams JM, Howe NR. Benzyl alcohol attenuates the pain of lidocaine injections and prolongs anesthesia. J Dermatol Surg Oncol. 1994 Nov. 20(11):730-3. [Medline].

Previous
Next
 
Table 1. Organic Solvents and Their Common Industrial Uses
CompoundIndustrial Uses
AcetoneCleaning solvent
AcrylamideMining and tunneling, adhesives, waste treatment, ore processing
BenzeneFuel, detergents, paint removers, manufacture of other solvents
Carbon disulfideViscose rayon, explosives, paints, preservatives, textiles, rubber cement, varnishes, electroplating
Ethylene oxide (ETO)Instrument sterilization
N- hexaneGlues and vegetable extraction, components of naphtha, lacquers, metal cleaning compounds
Hydrogen sulfideSulfur chemical manufacturing, by-product of petroleum processing, decay of organic matter
MethaneIndustrial settings
Methyl mercaptanOdorant in natural gas and fuels
Methyl-N- butyl ketoneMany industrial uses
Methylene chloride (dichloromethane)Solvent, refrigerant, propellant
OrganochlorineInsecticides
OrganophosphatesInsecticides
PCEDry cleaning, degreaser, textile industry
StyreneFiberglass component, ship building
ToluenePaint, fuel oil, cleaning agents, lacquers, paints and paint thinners
1,1,1-Trichloroethane (methyl chloroform)Degreaser and propellant
TCECleaning agent, paint component, decaffeination, rubber solvents, varnish
Vinyl chlorideIntermediate for polyvinylchloride resins for plastics, floor coverings, upholstery, appliances, packaging
XylenePaint, lacquers, varnishes, inks, dyes, adhesives, cements, fixative for pathologic specimens
Table 2. Exposure levels Believed Safe for Workers
CompoundUrineBloodExpired Air
AcetoneAcetone, formic acid 100 mg/LAcetoneAcetone
BenzeneTotal phenol 50 mg/g at the end of the shift, trans-trans- muconic acidBenzeneBenzene before shift, 0.08 ppm; end exhaled, 0.12 ppm
Carbon disulfide2-TTCA 5 mg/g*Carbon disulfideCarbon disulfide
ETONoneNoneNone
N- hexane2,5-hexanediol 5 mg/g at the end of the shift, 2-hexanol, total metabolitesN- hexaneN- hexane
Hydrogen sulfideNoneNoneNone
MethaneNoneNoneNone
Methyl mercaptanNoneNoneNone
MethanolFormic acid 80 mg/g at the start of the work week, methanol 15 mg/g at the end of the shiftNoneMethanol
Methyl-N- butyl ketoneNone2,5-hexane dioneNone
Methylene chlorideNoneMeCl2MeCl2
OrganochlorineNoneNoneNone
OrganophosphatesNoneNoneNone
PCEPCE, trichloroacetic acidPCE 1 mg/LPCE 10 ppm before the last shift of the week
StyreneEnd of the shift: mandelic acid (MA) 800 mg, phenylglyoxylic acid (PGA) 240 mg/g)



Before shift: MA 300 mg/g or PGA 100 mg/g



Styrene 0.02 mg/L at the start of the shift, 0.55 mg/L at the end of the shiftNone
TolueneHippuric acidTolueneToluene
1,1,1-Trichlorethane (methyl chloroform)TCA 10 mg/L at the end of the work week; total trichloroethanol at the end of the shift and at the end of the work week, 30 mg/L Total trichloroethanol 1 mg/LMethyl chloroform 40 ppm before the last shift of the work week
TCETCE, TCA 100 mg/g at the end of the work week or TCA plus trichloroethanol 300 mg/gTCE at the end of the work week 4 mg/LTCE
Vinyl chlorideNoneNoneNone
XyleneMethylhippuric acid 1.5 g/g at the end of the shiftXyleneXylene
* TTCA - 2-thiothiazolidine 4-carboxylic acid.
Table 3. Recommended Exposure Limits, Organic Solvents
Compoundppm, mg/m,3
OSHA PEL as TWAsNIOSH REL as TWAs, IDLHACGIH TLV, STEL
Acetone1000 (2400)250 (590), 2500750 (1780) ceiling, 1000 (2380)
Acrylamide0.3(0.03), 60 level for carcinogenicityNone
Benzene10, 25 ceiling, 50 for 10 min0.1, STEL 1, 50010 (32)
Carbon disulfide20, 30, 100 for 30 min1 (3), 10 STEL (30), 50010 (31)
ETO < 0.1, < 0.18, 5 ceiling, 8001 (1.8)
N- hexane500 (1800)50 (180), 110050 (176)
Hydrogen sulfide20 ceiling, 50 for 10 min once only10 ceiling, (15) for 10 min, 100None
Methyl mercaptan10 ceiling (20)0.5 ceiling, (1) for 15 min, 150None
Methanol200 (260)200 (260), 250 STEL (325), 6000262 (200), 328 (250)
Methyl-n- butyl ketone100 (410)None5 (20)
Methylene chloride25, 15 STEL for 15 min2300 level for carcinogenicity50 (174) ceiling
Perchloroethylene100, 200 ceiling, 300 for 5 min in 3 h150 level for carcinogenicity25 (170), 100 (685)
Styrene100, 200 ceiling, 600 for 5 min in 3 h50 (215), 100 ST (425), 70050 (213), 100 (428)
Toluene200, 300, 500 for 10 min100 (375), 150 STEL (560), 50050 (188)
1,1,1-Trichlorethane (methyl chloroform)350 (1900)Ceiling 350 (1900) for 15 min, 700350 (1910), 450 (2460)
Trichloroethylene100, 200 ceiling, 300 for 5 min in 2 h1000 level for carcinogenicity50 (269), 100 (1070)
Vinyl chloride1, 5 for 15 minNot determinedNone
Xylene100 (435)100 (435), 150 STEL (655)100 (434),150 (651)
Abbreviations—ACGIH = American Congress of Governmental Industrial Hygienists, IDLH = Immediately dangerous to life or health; NIOSH = National Institute for Occupational Safety and Health, OSHA = Occupational Safety and Health Administration, PEL = permissible exposure limit, REL = recommended exposure limit; STEL = short-term exposure limit; TWA = time-weighted average.
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.